CytomX
CTMX
2.55
-0.01
-0.39%
CytomX
US · CTMX
#3678 by market cap
Listed 2015
2.55
-0.01
-0.39%
Live - 5344 symbols - heartbeat 63s ago
· 2026-10-08 08:01
Pre-market
2.62
+2.65%
After-hours
2.54
-0.39%
Overnight
2.63
+3.14%
- Market cap
- 555.64M
- P/E (TTM)i
- -4.47
- P/Bi
- 1.84
- EPSi
- -0.15
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on CTMX?
Anonymous reader poll. Unscientific, not investment advice.
About CytomX
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.
- Founded
- 2010
- CEO
- Dr. Sean A. McCarthy, D.Phil.
- Employees
- 69
- Headquarters
- South San Francisco, California, United States of America
- Fiscal year end
- 12-31
- Website
- cytomx.com
Company profile
- Exchange
- US
- Symbol
- CTMX
- Market-cap rank
- #3678
- Listing date
- 2015-10-08
- Market cap
- 555.64M
- Float cap
- 458.14M
- Shares out
- 217.90M
- Float shares
- 179.66M
Sectors & themes
Quote time 2026-10-08 08:01:42 · For reference only, not investment advice and not tailored to your situation.